Today: 21 March 2026
Subscribe
Browse Category

NASDAQ:SGEN 9 January 2026

Merck (MRK) stock today: $32 billion Revolution talks and CDC vaccine shift put Feb. 3 in play

Merck (MRK) stock today: $32 billion Revolution talks and CDC vaccine shift put Feb. 3 in play

Merck shares rose 0.4% to $111.41 Friday after a report said it is in talks to buy Revolution Medicines for $28–32 billion. Revolution shares jumped 16% in extended trading. Merck just completed a $221.50-per-share tender offer for Cidara Therapeutics and said the deal will raise 2026 R&D expense by $9 billion. Analysts warned U.S. vaccine policy changes could cut Merck revenue by $2 billion annually.
9 January 2026
···

Stock Market Today

  • XRP Price Risks Amid Rising U.S. Recession Threat
    March 21, 2026, 6:34 PM EDT. Rising recession risks in the U.S., driven by geopolitical tensions, an oil price surge to above $95 per barrel, and Federal Reserve rate signals, weigh on XRP. The cryptocurrency has fallen 40% in 2026 already. Experts highlight that a recession could trigger sharper declines through reversed ETF investment flows and stalled legislative support tied to the Clarity Act. Goldman Sachs and JPMorgan place a one-in-three chance of recession within 12 months, reflecting higher oil prices and a cooling labor market. Inflation remains above the Fed's 2% target, limiting monetary easing, while economic contractions have historically followed oil shocks. Overall, XRP faces downside risks from both macroeconomic and regulatory shifts if a U.S. downturn materializes.
Go toTop